Your browser doesn't support javascript.
loading
Trial-based cost-effectiveness analysis of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus DSAEK.
Simons, Rob W P; Dickman, Mor M; van den Biggelaar, Frank J H M; Dirksen, Carmen D; Van Rooij, Jeroen; Remeijer, Lies; Van der Lelij, Allegonda; Wijdh, Robert H J; Kruit, Pieter J; Nuijts, Rudy M M A.
Afiliación
  • Simons RWP; Maastricht University Medical Center+, University Eye Clinic Maastricht, Maastricht, the Netherlands.
  • Dickman MM; Maastricht University Medical Center+, University Eye Clinic Maastricht, Maastricht, the Netherlands.
  • van den Biggelaar FJHM; Maastricht University Medical Center+, University Eye Clinic Maastricht, Maastricht, the Netherlands.
  • Dirksen CD; Department of Clinical Epidemiology and Medical Technology Assessment, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Van Rooij J; The Rotterdam Eye Hospital, Rotterdam, the Netherlands.
  • Remeijer L; The Rotterdam Eye Hospital, Rotterdam, the Netherlands.
  • Van der Lelij A; Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Wijdh RHJ; Department of Ophthalmology, Central Military Hospital, Utrecht, the Netherlands.
  • Kruit PJ; Department of Ophthalmology, University Medical Center Groningen, Groningen, the Netherlands.
  • Nuijts RMMA; Euro Tissue Bank, Beverwijk, the Netherlands.
Acta Ophthalmol ; 97(8): 756-763, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31025804
ABSTRACT

PURPOSE:

To evaluate the cost-effectiveness of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus standard DSAEK.

METHODS:

A cost-effectiveness analysis using data from a multicentre randomized clinical trial was performed. The time horizon was 12 months postoperatively. Sixty-four eyes of 64 patients with Fuchs' endothelial dystrophy were included and randomized to UT-DSAEK (n = 33) or DSAEK (n = 31). Relevant resources from healthcare and societal perspectives were included in the cost analysis. Quality-adjusted life years (QALYs) were determined using the Health Utilities Index Mark 3 questionnaire. The main outcome was the incremental cost-effectiveness ratio (ICER; incremental societal costs per QALY).

RESULTS:

Societal costs were €9431 (US$11 586) for UT-DSAEK and €9110 (US$11 192) for DSAEK. Quality-adjusted life years (QALYs) were 0.74 in both groups. The ICER indicated inferiority of UT-DSAEK. The cost-effectiveness probability ranged from 37% to 42%, assuming the maximum acceptable ICER ranged from €2500-€80 000 (US$3071-US$98 280) per QALY. Additional analyses were performed omitting one UT-DSAEK patient who required a regraft [ICER €9057 (US$11 127) per QALY, cost-effectiveness probability 44-62%] and correcting QALYs for an imbalance in baseline utilities [ICER €23 827 (US$29 271) per QALY, cost-effectiveness probability 36-59%]. Furthermore, the ICER was €2101 (US$2581) per patient with clinical improvement in best spectacle-corrected visual acuity (≥0.2 logMAR) and €3274 (US$4022) per patient with clinical improvement in National Eye Institute Visual Functioning Questionnaire-25 composite score (≥10 points).

CONCLUSION:

The base case analysis favoured DSAEK, since costs of UT-DSAEK were higher while QALYs were comparable. However, additional analyses revealed no preference for UT-DSAEK or DSAEK. Further cost-effectiveness studies are required to reduce uncertainty.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Asunto principal: Oftalmología / Agudeza Visual / Distrofia Endotelial de Fuchs / Costos de la Atención en Salud / Queratoplastia Endotelial de la Lámina Limitante Posterior Tipo de estudio: Health_economic_evaluation / Observational_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Acta Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Asunto principal: Oftalmología / Agudeza Visual / Distrofia Endotelial de Fuchs / Costos de la Atención en Salud / Queratoplastia Endotelial de la Lámina Limitante Posterior Tipo de estudio: Health_economic_evaluation / Observational_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Acta Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
...